New drug combo shows promise for rare liver disease in early trial
Disease control
Completed
This early-phase study tested whether adding fenofibrate to standard treatment (ursodeoxycholic acid) helps people newly diagnosed with primary biliary cholangitis, a chronic liver disease. Thirty adults participated to see if the combination could normalize liver enzyme levels a…
Phase: EARLY_PHASE1 • Sponsor: Han Ying • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC